Skip to main content
Clinical Trials/NCT05018052
NCT05018052UnknownNot Applicable

Characteristics and Predictors of Early and Late Cardiovascular Complications of Covid-19 Patients - the PoLoCOV-Study (Polish LONG-COVID Cardiovascular Study)

Michal Chudzik1 site in 1 country1,900 target enrollmentStarted: May 29, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
1,900
Locations
1
Primary Endpoint
Early and Late COVID-19 cardio-vascular complications

Study Overview

Brief Summary

Coronavirus disease 2019 (COVID-19) is a serious respiratory disease that results from infection with a newly discovered coronavirus (SARS-COV-2). Unfortunately, COVID-19 is not only a short-term infection. Patients (pts) recovering from SARS-COV2 infection complain of persisting symptoms including: fatigue, diffuse myalgia and weakness, which may lead to chronic fatigue syndrome and as well as many other complications.

The vast majority of COVID-19 patients remaining in isolation/quarantine, due to the mild course of the disease, do not require hospitalization. In this group of patients, the course of COVID-19 is very different - from asymptomatic patients to very severe and long lasting symptoms also with a decrease in saturation.

There are many studies describing the course and complications of patients hospitalized due to COVID-19. There is little published data on how non-hospitalized patients get sick and what are the early and late complications of SARS-CoV-2 infection. In addition, many patients remain ill even many months after COVID-19, entering what is known as LONG-COVID.

Therefore, the STOP-COVID Registry was established. The purpose of the Registry is to assess the course of COVID-19 infection, early and late cardiovascular complications of COVID-19 in patients with and without hospitalization. In addition, the purpose of the STOP-COVID Registry is to assess the incidence of LONG-COVID with all other complications and to identify predictive factors.

Detailed Description

The following patients are included in the Registry: Patients 18 years and older diagnosed with COVID-19, in accordance with the current guidelines of the Ministry of Health of Poland, after full recovery (resolution of clinical symptoms, minimum 14 days after last symptoms). The Registry includes patients with and without hospitalization .

Approval from the Bioethics Committee of Lodz Regional Medical Chamber to conduct the Registry was obtained.

The Registry was held at the: Saint Family Hospital Medical Center, Lodz, Poland Patient information, course of the disease, post-COVID-19 complaints, comorbidities and current treatment were collected at visit "0" within 4-8 weeks after the end of COVID-19.

Subsequently, patients were ordered the following tests:

  • 12-lead ECG
  • 24-hour Holter ECG monitoring
  • 24-hour Holter blood pressure monitoring
  • Echocardiographic of the Heart assessment
  • Biochemical tests: Lipid Profile (total cholesterol, LDL fraction, HDL, triglycerides), glucose or glycosylated hemoglobin (HbA1c) level, D-dimers.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Other

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients after COVID-19, 18 years and older

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Early and Late COVID-19 cardio-vascular complications

Time Frame: 5 years

Early and Late COVID-19 cardio-vascular complications

Predictors of Long-Covid Cardio-Vascular complications

Time Frame: 5 years

Predictors of Long-Covid Cardio-Vascular complications

SCORE - algorithm to help to predict the highest risk of Long-Covid complications

Time Frame: 5 years

SCORE - algorithm to help to predict the highest risk of Long-Covid complications

Secondary Outcomes

  • Detailed patients' characteristics and differences in those with and without Long-Covid complications(5 years)
  • Definition and characteristics of the early and Late COVID-19 complications(5 years)
  • Comparison of complications and Long-Covid depending on the severity of the course of COVID-19 COVID-19, comorbidities(5 years)

Investigators

Sponsor
Michal Chudzik
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Michal Chudzik

Medical Doctor, Cardiologist, Medical Director Ambulatory Clinic

Saint Family Hospital Medical Center

Study Sites (1)

Loading locations...

Similar Trials